About CraniUS
CraniUS is a company based in Baltimore (United States) founded in 2021 by Chad Gordon.. CraniUS has raised $20.5 million across 3 funding rounds from investors including Maryland.gov, Mumbai Angels and Lumis Partners. CraniUS offers products and services including NeuroPASS. CraniUS operates in a competitive market with competitors including Impel NeuroPharma, Cognos Therapeutics, Cordance Medical, PassPort Technologies and Bionxt, among others.
- Headquarter Baltimore, United States
- Founders Chad Gordon
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$20.5 M (USD)
in 3 rounds
-
Latest Funding Round
$1 M (USD), Grant
Jun 26, 2024
-
Investors
Maryland.gov
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CraniUS
CraniUS offers a comprehensive portfolio of products and services, including NeuroPASS. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Skull-implantable device for targeted brain disease treatment and drug administration.
Unlock access to complete
Operations Team
1 people
Leadership Team
1 people
Product Management Team
1 people
Sales and Marketing
1 people
Unlock access to complete
Funding Insights of CraniUS
CraniUS has successfully raised a total of $20.5M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $1 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $1.0M
-
First Round
First Round
(04 Aug 2021)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2024 | Amount | Grant - CraniUS | Valuation |
investors |
|
| Sep, 2022 | Amount | Series A - CraniUS | Valuation |
investors |
|
| Aug, 2021 | Amount | Seed - CraniUS | Valuation | Mumbai Angels |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CraniUS
CraniUS has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Maryland.gov, Mumbai Angels and Lumis Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture investments are facilitated by Mumbai Angels network.
|
Founded Year | Domain | Location | |
|
Investment in alternative assets, businesses, and funds in India.
|
Founded Year | Domain | Location | |
|
Access to government programs and development services is facilitated.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CraniUS
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CraniUS
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cranius Comparisons
Competitors of CraniUS
CraniUS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Impel NeuroPharma, Cognos Therapeutics, Cordance Medical, PassPort Technologies and Bionxt, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Intranasal delivery technology for CNS diseases is developed.
|
|
| domain | founded_year | HQ Location |
Cognos Therapeutics is focused on innovative neurological and oncological treatments.
|
|
| domain | founded_year | HQ Location |
Non-invasive ultrasound device for blood-brain barrier is developed.
|
|
| domain | founded_year | HQ Location |
Transdermal drug delivery systems are developed using microporation technology.
|
|
| domain | founded_year | HQ Location |
Drug formulations and delivery systems for diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cranius
Frequently Asked Questions about CraniUS
When was CraniUS founded?
CraniUS was founded in 2021.
Where is CraniUS located?
CraniUS is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
Who is the current CEO of CraniUS?
Michael Maglin is the current CEO of CraniUS.
Is CraniUS a funded company?
CraniUS is a funded company, having raised a total of $20.5M across 3 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on Aug 04, 2021.
What does CraniUS do?
CraniUS was founded in 2021 in Baltimore, United States, as a medical technology company. Implantable devices are developed by the company for brain tumor treatment and to address disorders such as Alzheimers and Parkinsons. The flagship product, NeuroPASS, is designed to deliver medication directly to the brain, bypassing the blood-brain barrier with controlled flow rates. Operations focus on innovative drug delivery solutions within the neurotherapeutics sector.
Who are the top competitors of CraniUS?
CraniUS's top competitors include Impel NeuroPharma, Cognos Therapeutics and Cordance Medical.
What products or services does CraniUS offer?
CraniUS offers NeuroPASS.
Who are CraniUS's investors?
CraniUS has 3 investors. Key investors include Maryland.gov, Mumbai Angels, and Lumis Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.